Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Glenmark Pharmaceuticals Inc., USA

US Class II Ongoing · initiated 2026-05-27

Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

SUN PHARMACEUTICAL INDUSTRIES INC

US Class II Ongoing · initiated 2026-05-22

Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona

SUN PHARMACEUTICAL INDUSTRIES INC

US Class II Ongoing · initiated 2026-05-22

Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by FDA of marketing the product under the proprietary name Xyvona

Zep Inc

US Class II Ongoing · initiated 2026-05-22

Microbial contamination of sterile products

Keystone Industries

US Class II Ongoing · initiated 2026-05-21

Defective container:may contain bottles with incomplete seals

Keystone Industries

US Class II Ongoing · initiated 2026-05-21

Defective container:may contain bottles with incomplete seals

Keystone Industries

US Class II Ongoing · initiated 2026-05-21

Defective container:may contain bottles with incomplete seals

Keystone Industries

US Class II Ongoing · initiated 2026-05-21

Defective container:may contain bottles with incomplete seals

Keystone Industries

US Class II Ongoing · initiated 2026-05-21

Defective container:may contain bottles with incomplete seals

Keystone Industries

US Class II Ongoing · initiated 2026-05-21

Defective container:may contain bottles with incomplete seals

Keystone Industries

US Class II Ongoing · initiated 2026-05-21

Defective container:may contain bottles with incomplete seals

Kirkland Signature Women 50+ multivitamin

Canada Type II Ongoing · initiated 2026-05-21

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

Personnelle Supravite Energizing Formula

Canada Type II Ongoing · initiated 2026-05-20

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

ERYTHROMYCIN OPHTHALMIC OINTMENT USP

Canada Type II Ongoing · initiated 2026-05-20

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

Shimoga Chemicals

US Class II Ongoing · initiated 2026-05-19

cGMP deviations

Honibe Honey Gummies Melatonin / Honibe Gummie Bees Melatonin Sleep Support

Canada Type II Ongoing · initiated 2026-05-19

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

AbbVie Inc.

US Class III Ongoing · initiated 2026-05-18

Failed Stability Specifications

Eugia US LLC

US Class III Ongoing · initiated 2026-05-18

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

IntegraDose Compounding Services LLC

US Class II Ongoing · initiated 2026-05-18

Subpotent Drug

PReye LLC

US Class II Ongoing · initiated 2026-05-18

Lack of Assurance of Sterility

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

AVEVA Drug Delivery Systems, Inc.

US Class III Ongoing · initiated 2026-05-14

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of i…